WGS GENEDX HOLDINGS CORP
2026Q1 · CUSIP 81663L200 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
239
Δ holders QoQ
-47
Breadth percentile
Top 97%
Whale holders
126
Δ whales
-9
Inst. holding value
$2.0B
New positions
41
Closed positions
88
Price momentum (1Q)
-53.1%
Put / Call
5/8
Breadth history (34 quarters)
Past Lit Events & Aftermath 6 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q3 | Top 8% | -30.0% | -65.5% |
| 2025Q1 | Top 7% | +69.9% | +82.4% |
| 2024Q4 | Top 7% | -37.0% | +7.0% |
| 2024Q3 | Top 4% | +34.8% | -5.3% |
| 2024Q2 | Top 8% | +113.3% | +222.0% |
| 2023Q2 | Top 2% | — | — |
Options Sentiment
Put holders
5
QoQ: -7
Call holders
8
QoQ: -3
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-2.66
EPS YoY
—
Revenue (TTM)
$0.4B
Revenue YoY
+34.1%
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
As of 2026-03-31 · SEC filings (XBRL)